Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients

Clinical trial NCT05619562 · COMPLETED

Trial details

NCT number: NCT05619562
Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic
Status: COMPLETED
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Circulating Tumor Cell

Start date: 2009-01-01
Primary completion: 2013-04-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.